Your browser doesn't support javascript.
loading
The Growing Relevance of Immunoregulation in Pediatric Brain Tumors.
Melcher, Viktoria; Kerl, Kornelius.
Afiliação
  • Melcher V; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, 48149 Münster, Germany.
  • Kerl K; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, 48149 Münster, Germany.
Cancers (Basel) ; 13(22)2021 Nov 09.
Article em En | MEDLINE | ID: mdl-34830753
ABSTRACT
Pediatric brain tumors are genetically heterogeneous solid neoplasms. With a prevailing poor prognosis and widespread resistance to conventional multimodal therapy, these aggressive tumors are the leading cause of childhood cancer-related deaths worldwide. Advancement in molecular research revealed their unique genetic and epigenetic characteristics and paved the way for more defined prognostication and targeted therapeutic approaches. Furthermore, uncovering the intratumoral metrics on a single-cell level placed non-malignant cell populations such as innate immune cells into the context of tumor manifestation and progression. Targeting immune cells in pediatric brain tumors entails unique challenges but promising opportunities to improve outcome. Herein, we outline the current understanding of the role of the immune regulation in pediatric brain tumors.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha